WORX - Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.
4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Chenghe Acquisition Co. (NASDAQ: CHEA) gained 68.1% to $9.23 in pre-market trading after dipping around 46% on Friday.
- Tritium DCFC Limited (NASDAQ: DCFC) shares jumped 51.9% to $0.1990 in pre-market trading. Tritium DCFC said the company was the top-awarded fast charger manufacturer for the first round of the State of Tennessee’s National Electric Vehicle Infrastructure (NEVI) Formula Program.
- YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 27.4% to $0.7641 in pre-market trading after falling around 19% on Friday.
- Magic Empire Global Limited (NASDAQ: MEGL) shares gained 21.6% to $0.9841 in pre-market trading.
- CalAmp Corp. (NASDAQ: CAMP) ...